Skip to main navigation
About us Our science Our programs Patients Investors Careers
About us Our science Our programs Patients Investors Careers
Presentations
Overview
News & Events
News Releases
Events
Presentations
Stock Information
Stock Quote & Chart
Corporate Governance
Documents & Charters
Board of Directors
Leadership
Committee Composition
Financial Information
SEC Filings
Annual Reports
Quarterly Results
IR Resources
Investor FAQs
Email Alerts
Contact IR

Presentations

May 27, 2026
APEX Phase 2 Part B 16-Week Results for Zumilokibart 1.6 MB
March 23, 2026
APEX Phase 2 Part A 52-Week Results for Zumilokibart 2.1 MB
January 6, 2026
Zumilokibart Asthma Ph1b Interim Results 1.5 MB
November 10, 2025
APG333 Ph1 HV Data Presentation 1.9 MB
September 19, 2025
APG777 Part A Data Presentation – EADV Update 245 KB
July 7, 2025
APG777 Part A Data Presentation 1.3 MB
Subscribe
to stay updated
Our science Background & Goal Approach Therapeutic Targets Publications
Our programs Pipeline Programs
About us Story & Mission People Contact
Careers Values Benefits Careers
Patients Apogee Commitment Science Simplified Clinical Trials & Disease Ed
Investors Corporate Presentation Overview News & Events Stock Information Corporate Governance Financial Information IR Resources
Terms of Service Privacy Policy Cookies Policy
© 2026 Apogee Therapeutics, Inc. All rights reserved.
Design by Visual Science 2024